Supreme Pharmaceuticals Announces Debt Settlement for Shares
(firmenpresse) - TORONTO, ONTARIO -- (Marketwired) -- 10/22/15 -- Supreme Pharmaceuticals Inc. (the "Company") (OTC PINK: SPRWF)(CSE: SL) advises that it has settled outstanding debts by the issuance of 215,000 common shares at a weighted average price of $0.125 per share. These shares shall be subject to a 4 month trading restriction.
About Supreme
Supreme is a Canadian publically traded company committed to becoming a leading supplier of affordable medical cannabis achieved by applying commercial agriculture practices to medical cannabis production. Supreme''s flagship facility is a 342,000 sq. ft. hybrid greenhouse located in Kincardine, Ontario, which has been designed to maximize production efficiencies allowing the Company to pass savings along to its future patients.
Contacts:
Supreme Pharmaceuticals Inc.
Investor Relations
(416) 630-7272
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 22.10.2015 - 17:19 Uhr
Sprache: Deutsch
News-ID 1394234
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
TORONTO, ONTARIO
Phone:
Kategorie:
Healthcare
Anmerkungen:
Diese Pressemitteilung wurde bisher 231 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Supreme Pharmaceuticals Announces Debt Settlement for Shares
"
steht unter der journalistisch-redaktionellen Verantwortung von
Supreme Pharmaceuticals Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
